The global human leukocyte antigen (HLA) typing for the transplant market is anticipated to grow at a CAGR of around 6.5% during the forecast period. The factors augmenting the growth of the global HLA typing for the transplant market are the increasing demand for transplant diagnostic products and the increase in transplant procedures owing to the rising geriatric population coupled with organ failures. According to the Population Reference Bureau’s Population Bulletin, the number of Americans ages 65 and older is projected to nearly double from 52 million in 2018 to 95 million by 2060. Hence, the elderly population is more prone to age-related diseases and they are at high risk of organ failures, due to this the growth in demand for HLA typing such as PCR-based molecular assays for transplant procedures can be witnessed during the forecast period. Moreover, the continuous technological advancements in molecular diagnosis will increase the use of HLA typing for transplant.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/hla-typing-transplant-market
Moreover, the key market players are also contributing towards the growth of the HLA typing for transplant market by adopting various strategies such as new product launches, business expansion, and partnership collaboration. For instance, Omixon announced the new distribution channels in Mexico and India to further accelerating its international commercial expansion of Omixon’s high-performance, high-throughput, and high-resolution multi-sample kit and software products for HLA genotyping analysis by NGS. Moreover, in October 2020, Thermo Fisher Scientific signed a partnership agreement with Terasaki Innovation Center (TIC). Through this partnership, Thermo Fisher Scientific will facilitate the discovery and development of tools to diagnose and manage transplant patients. These key strategies are expected to create considerable growth in the market during the forecast period.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered-
o By Technology
o By Product & Services
o By Applications
o By End-Users
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- Biofortuna Ltd., Bio-Rad Laboratories, Inc, F. Hoffmann-La Roche Ltd., Illumina, Inc., Luminex Corp., QIAGEN, Thermo Fisher Scientific Inc., among others
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global HLA typing for Transplant Market Report Segment
By Technology
- Non-Molecular Assays
o Serological Assays
o Mixed Lymphocyte Culture Assays
- Molecular Assays
o PCR-Based Molecular Assay
? Sequence-Specific Primer (SSP-PCR)
? Sequence-Specific Oligonucleotide (SSO-PCR)
? Sequence-Based Typing (SBT-PCR)
? Others
o Sequencing-Based Molecular Assays
? Sanger Sequencing
? Next-Generation Sequencing
By Product & Services
- Reagents
- Software
- Instruments
By Application
- Diagnostics
- Research
By End-Users
- Academic Institutes & Research Centers
- Hospitals & Transplant Centers
- Donor Registries
A full report of HLA Typing for Transplant Market is available at: https://www.omrglobal.com/industry-reports/hla-typing-transplant-market
HLA Typing for Transplant Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Biofortuna Ltd.
- Bio-Rad Laboratories, Inc
- Biotron Healthcare Pvt. Ltd.
- Creative-Biolabs Inc.
- Hoffmann-La Roche Ltd.
- FujirebioDiagnostics, Inc.
- Genome Diagnostics B.V.
- HistoGenetics LLC
- Illumina, Inc.
- Immucor Inc.
- Integrated Gulf Biosystems
- MC Diagnostics Ltd.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
